The 15th annual Clinical Trials on Alzheimer’s Disease (CTAD) will be held in San Francisco on November 29 – December 2, 2022.
GNS today announced an oral poster presentation and an abstract highlighting insight from the Gemini Digital Twin model in Alzheimer Disease.
Oral Poster Presentation:
Friday, December 2nd from 8am to 5pm PT.
Abstract Title: Causal in silico patient models can inform Alzheimer’s disease patient identification and endpoint selection for early-stage clinical trials
The poster and abstract will be made available on the CTAD website following the presentations at the conference.
For more information on CTAD Conference, please visit www.ctad-alzheimer.com
You want to know more? Reach out and let us know if you’d like to schedule a meeting beforehand and discuss drug discovery partnership opportunities.